Your browser is no longer supported. Please, upgrade your browser.
Settings
OSUR OraSure Technologies, Inc. daily Stock Chart
OSUR [NASD]
OraSure Technologies, Inc.
Index- P/E31.48 EPS (ttm)0.35 Insider Own3.20% Shs Outstand55.08M Perf Week2.03%
Market Cap610.29M Forward P/E45.79 EPS next Y0.24 Insider Trans-33.13% Shs Float53.66M Perf Month30.66%
Income19.70M PEG1.57 EPS next Q0.18 Inst Own82.20% Short Float1.65% Perf Quarter28.69%
Sales128.20M P/S4.76 EPS this Y143.60% Inst Trans-2.82% Short Ratio1.55 Perf Half Y58.51%
Book/sh3.33 P/B3.33 EPS next Y-35.81% ROA9.90% Target Price11.21 Perf Year72.05%
Cash/sh2.20 P/C5.04 EPS next 5Y20.00% ROE11.40% 52W Range5.57 - 11.41 Perf YTD26.20%
Dividend- P/FCF- EPS past 5Y31.00% ROI10.60% 52W High-2.89% Beta1.62
Dividend %- Quick Ratio8.30 Sales past 5Y9.40% Gross Margin68.70% 52W Low98.92% ATR0.40
Employees326 Current Ratio9.00 Sales Q/Q9.60% Oper. Margin15.90% RSI (14)76.53 Volatility3.48% 3.67%
OptionableYes Debt/Eq0.00 EPS Q/Q59.60% Profit Margin15.40% Rel Volume1.35 Prev Close11.00
ShortableYes LT Debt/Eq0.00 EarningsFeb 08 AMC Payout0.00% Avg Volume568.82K Price11.08
Recom1.70 SMA2015.41% SMA5021.01% SMA20039.72% Volume769,928 Change0.73%
Feb-09-17Upgrade Raymond James Mkt Perform → Outperform
Jun-13-16Downgrade Raymond James Outperform → Mkt Perform
Nov-05-15Reiterated Mizuho Buy $12 → $8
May-07-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-23-15Reiterated Mizuho Buy $10 → $12
Jun-12-14Reiterated Canaccord Genuity Buy $10 → $11
Jun-11-14Reiterated Mizuho Buy $9 → $10
Dec-21-12Initiated Mizuho Buy $9
Aug-08-12Upgrade Barrington Research Mkt Perform → Outperform $12.50
Jul-05-12Downgrade Barrington Research Outperform → Mkt Perform
Mar-27-12Initiated JMP Securities Mkt Outperform $15
Mar-21-12Upgrade MLV & Co Hold → Buy $11 → $13
Feb-09-12Downgrade MLV & Co Buy → Hold $11
Jul-01-11Resumed Barrington Research Outperform $10
Nov-30-10Initiated Barrington Research Outperform $8
Nov-16-10Initiated Canaccord Genuity Buy $8
Nov-17-09Upgrade Needham Hold → Buy $5.50
May-04-09Reiterated FBR Capital Markets Mkt Perform $17 → $16
Jun-20-08Downgrade Needham Buy → Hold
May-07-08Reiterated Susquehanna Financial Positive $12 → $10
Feb-17-17 08:39AM  Surging Earnings Estimates Signal Good News for OraSure (OSUR)
Feb-16-17 09:30AM  Zacks.com featured highlights: Rush Enterprises, Louisiana-Pacific, Alliance Resource Partners, Teradyne and OraSure Technologies
Feb-15-17 11:25AM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
Feb-13-17 09:30AM  Zacks.com featured highlights: Brooks Automation, United States Steel, Everest Re Group, OraSure Technologies and Soffa Industries and TTM Technologies
Feb-10-17 05:00PM  OraSure Technologies, Inc.: Leads amongst peers with strong fundamentals
02:04PM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017
08:30AM  Want to Gain from Relative Price Strength? 5 Stocks to Buy
Feb-09-17 01:35PM  Why OraSure Technologies, Inc. Leaped Higher Today at Motley Fool +18.53%
11:45AM  3 Quiet Earnings Reports Making the Biggest Moves on Thursday
06:34AM  OraSure upgraded by Raymond James
Feb-08-17 10:02PM  Edited Transcript of OSUR earnings conference call or presentation 8-Feb-17 10:00pm GMT
05:11PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
05:00PM  OraSure Technologies Inc Earnings Call scheduled for 5:00 pm ET today
04:32PM  OraSure posts 4Q profit
04:00PM  OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results GlobeNewswire
07:07AM  Q4 2016 OraSure Technologies Inc Earnings Release - 4:00 pm ET
Feb-06-17 07:55AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA GlobeNewswire
Feb-01-17 07:26AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : February 1, 2017
Jan-31-17 09:38AM  AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Lag
Jan-30-17 09:30AM  Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
08:20AM  Hill-Rom (HRC) Q1 Earnings Meet, Revenues Lag Estimates
Jan-27-17 08:38AM  Abaxis (ABAX) Q3 Bleak: Earnings In Line, Revenues Miss
08:12AM  Cardiovascular Systems (CSII) Q2 Earnings Better Estimates
Jan-26-17 03:24PM  Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17
09:45AM  Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View
06:43AM  PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues
Jan-25-17 11:00AM  Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line
Jan-24-17 08:12AM  ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
Jan-23-17 12:16PM  OraSure Technologies, Inc. Value Analysis (NASDAQ:OSUR) : January 23, 2017
Jan-20-17 08:30AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : January 20, 2017
Jan-11-17 06:00AM  OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Dec-09-16 01:32PM  Is Progenics Pharmaceuticals, Inc. (PGNX) a Good Stock to Buy? at Insider Monkey
Dec-01-16 04:21PM  OraSure Stock Sets Up For Buy Point On Hep C Contract, Helix Win
Nov-29-16 01:29PM  Hedge Funds Are Unsure of OraSure Technologies, Inc. (OSUR) at Insider Monkey
08:22AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program GlobeNewswire
06:00AM  Helix Selects DNA Genoteks Oragene® Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications GlobeNewswire
Nov-28-16 10:00AM  OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire -5.49%
Nov-21-16 06:00AM  OraSure Technologies to Host Analyst Day GlobeNewswire
Nov-16-16 01:04PM  ORASURE TECHNOLOGIES INC Financials
Nov-15-16 08:40AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
06:00AM  OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors GlobeNewswire
Nov-14-16 07:56AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : November 14, 2016
Nov-09-16 06:00AM  OraSure Technologies to Present at the 10th Annual Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire
Nov-08-16 04:12PM  ORASURE TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
12:30PM  ETFs with exposure to OraSure Technologies, Inc. : November 8, 2016
Nov-07-16 10:48AM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
Nov-02-16 09:40PM  Edited Transcript of OSUR earnings conference call or presentation 2-Nov-16 9:00pm GMT
05:33PM  OraSure posts 3Q profit
05:11PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
05:00PM  OraSure Technologies Inc Earnings Call scheduled for 5:00 pm ET today
04:00PM  OraSure Announces 2016 Third Quarter Financial Results GlobeNewswire
07:07AM  Q3 2016 OraSure Technologies Inc Earnings Release - 4:00 pm ET
Oct-14-16 06:00AM  OraSure Technologies Announces 2017 Annual Meeting Date GlobeNewswire
Oct-12-16 08:43AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : October 12, 2016
06:00AM  OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Oct-08-16 09:22AM  Five Cheap Healthcare Stocks Poised to Explode at Insider Monkey
Oct-06-16 10:00AM  Theranos Exits Lab Business at Forbes
Oct-05-16 04:09PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Sep-30-16 09:30AM  Zacks.com featured highlights: Energy Recovery, Simpson Manufacturing, OraSure Technologies, Provident Financial Services and National Bank Holdings
Sep-19-16 08:36AM  BTIG Downgrades OraSure Technologies To Neutral Citing Valuation
Sep-14-16 09:07AM  5 Stocks Set to Pop on New Analyst Coverage
Sep-07-16 09:30AM  The Zacks Analyst Blog Highlights: Inovio Pharmaceuticals, OraSure Technologies, GlaxoSmithKline, Sanofi and Spectrum Brands
Sep-06-16 08:00AM  6 Drug Stocks in Focus as Zika Virus Fear Spreads
06:00AM  OraSure Technologies to Present at the CL King 14th Annual Best Ideas Conference GlobeNewswire
Sep-05-16 07:04AM  Why Inovio Pharmaceuticals Isn't the Best Zika Stock Right Now at Motley Fool
Sep-02-16 09:29AM  How The Zika Virus Spread While Congress Was Out On Recess
Aug-29-16 04:19PM  Why OraSure Technologies, Inc Rose Today at Motley Fool +10.32%
12:14PM  OraSure (OSUR) Stock Spikes, Upgraded at Stephens
06:00AM  DNA Genoteks OMNIgene® GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome GlobeNewswire
Aug-27-16 10:05AM  FDA Recommends Zika Test for All Blood Donations at 24/7 Wall St.
Aug-25-16 04:15PM  OraSure Technologies, Inc.: Leads amongst peers with strong fundamentals
10:42AM  4 Stocks for Fighting Zika
Aug-24-16 03:55PM  OraSure Gets Zika Contract, Canaccord Raises Price Target +10.57%
03:52PM  OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract
12:10PM  Why OraSure Technologies, Inc is Jumping Today at Motley Fool
10:10AM  Federal Funding Approved for Rapid Zika Virus Test at 24/7 Wall St.
08:45AM  Morning Movers: EXPR, OSUR, LZB, OAS
Aug-23-16 05:25PM  [$$] OraSure Gets U.S. Contract to Hurry Development of Zika Test at The Wall Street Journal
04:00PM  OraSure Awarded Up to $16.6 Million to Advance Rapid Zika Tests GlobeNewswire
Aug-15-16 01:21PM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-08-16 04:38PM  ORASURE TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
02:31PM  ETFs with exposure to OraSure Technologies, Inc. : August 8, 2016
Aug-05-16 08:06AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : August 5, 2016
Aug-03-16 05:13PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
05:07PM  OraSure posts 2Q profit
05:00PM  OraSure Technologies Inc Earnings Call scheduled for 5:00 pm ET today
04:00PM  OraSure Announces 2016 Second Quarter Financial Results GlobeNewswire
07:07AM  Q2 2016 OraSure Technologies Inc Earnings Release - 4:00 pm ET
Aug-01-16 06:00AM  OraSure Technologies to Present at the Canaccord Genuity 36th Annual Growth Conference GlobeNewswire
Jul-13-16 09:10AM  Coverage Initiated on Select Healthcare Stocks
06:00AM  OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Jul-05-16 07:00AM  Recro Pharma Appoints Michael Celano as Chief Financial Officer GlobeNewswire
Jul-01-16 08:37AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material De
08:34AM  OraSure's stock drops after co-promotion pact with AbbVie ends early at MarketWatch
08:30AM  Reinsurance Group of America Inc Earnings Call scheduled for 8:30 am ET today
06:00AM  OraSure Technologies and AbbVie Agree to an Early Termination of HCV Co-Promotion Agreement GlobeNewswire
Jun-30-16 05:00PM  OraSure Technologies Investor Call Invitation GlobeNewswire -16.53%
Jun-17-16 12:14PM  OraSure Technologies, Inc. Value Analysis (NASDAQ:OSUR) : June 17, 2016
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HCV, OraQuick In-Home HIV Test, OraQuick Ebola, OraSure QuickFlu Rapid Flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, OMNIgene Gut, OMNIgene Sputum, PrepIT MAX, Intercept, MICRO-PLATE DOA Assays, Intercept i2, Homogeneous DOA Assays, and professional and over-the-counter Cryosurgical Systems. In addition, the company manufactures and sells oral fluid collection devices used to collect, stabilize, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, and microbiome and animal genetics markets. Further, it provides medical devices used for the removal of benign skin lesions by cryosurgery or freezing; various immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets and sells its products to various clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPAIR RONALD HCOO & CFOFeb 16Sale11.1250,000555,780150,063Feb 16 05:33 PM
JERRETT JACK ESVP & General CounselFeb 15Option Exercise6.47107,288694,218163,130Feb 16 05:31 PM
TANG STEPHEN S PHDDirectorFeb 15Option Exercise8.2140,000328,20078,068Feb 16 05:34 PM
TANG STEPHEN S PHDDirectorFeb 15Sale11.0440,000441,75638,068Feb 16 05:34 PM
JERRETT JACK ESVP & General CounselFeb 15Sale11.06107,2881,186,47758,842Feb 16 05:31 PM
SPAIR RONALD HCOO & CFOFeb 14Option Exercise2.812,9268,207118,314Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 14Sale10.659,24898,449109,066Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 13Option Exercise2.8115,79444,302169,860Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 13Sale10.5954,472576,897115,388Feb 15 05:03 PM
KUNA MARK LSVP & ControllerFeb 10Option Exercise6.1964,271397,973127,762Feb 13 04:38 PM
KUNA MARK LSVP & ControllerFeb 10Sale10.7564,271690,78563,491Feb 13 04:38 PM
Michels Douglas APresident & CEOFeb 09Option Exercise4.07193,355786,501961,413Feb 13 04:39 PM
TANG STEPHEN S PHDDirectorFeb 09Sale10.2312,641129,29238,068Feb 13 04:41 PM
Michels Douglas APresident & CEOFeb 09Sale10.21193,3551,974,271768,058Feb 13 04:39 PM
KUNA MARK LSVP & ControllerFeb 09Sale10.0015,000150,00063,491Feb 13 04:38 PM
Celano MichaelDirectorFeb 09Sale10.0610,000100,60083,079Feb 13 04:37 PM
PRINGLE ROGER LDirectorFeb 01Option Exercise8.2815,000124,12550,476Feb 02 07:04 PM
SPAIR RONALD HCOO & CFOFeb 01Option Exercise8.2845,000372,375154,066Feb 02 06:32 PM
Patrick Charles WDirectorFeb 01Option Exercise8.2815,000124,12589,959Feb 02 06:22 PM
LANCASTER RONNY BDirectorFeb 01Option Exercise8.2815,000124,12578,603Feb 02 06:19 PM
Celano MichaelDirectorJan 31Option Exercise8.2815,000124,125108,079Feb 02 06:14 PM
Celano MichaelDirectorJan 31Sale8.7815,000131,70093,079Feb 02 06:14 PM
SPAIR RONALD HCOO & CFOJan 17Sale8.713,34129,103160,810Jan 19 05:02 PM
KUNA MARK LSVP & ControllerDec 15Option Exercise8.0610,00080,55082,965Dec 16 04:56 PM
KUNA MARK LSVP & ControllerDec 15Sale9.3010,00093,00072,965Dec 16 04:56 PM
Michels Douglas APresident & CEODec 13Option Exercise8.1071,466579,006803,364Dec 14 09:07 PM
KUNA MARK LSVP & ControllerDec 13Option Exercise8.2117,000139,57589,965Dec 14 09:09 PM
KUNA MARK LSVP & ControllerDec 13Sale9.1117,000154,85072,965Dec 14 09:09 PM
Michels Douglas APresident & CEODec 13Sale9.0771,466647,998731,898Dec 14 09:07 PM
KUNA MARK LSVP & ControllerDec 09Option Exercise8.283,00024,82575,965Dec 12 01:02 PM
Michels Douglas APresident & CEODec 09Option Exercise8.2823,891197,698755,789Dec 12 12:46 PM
KUNA MARK LSVP & ControllerDec 09Sale9.033,00027,09072,965Dec 12 01:02 PM
JERRETT JACK ESVP & General CounselNov 23Option Exercise8.1724,000195,96072,105Nov 25 05:53 PM
KUNA MARK LSVP & ControllerNov 23Option Exercise2.867,13120,42095,096Nov 25 05:55 PM
Michels Douglas APresident & CEONov 23Option Exercise8.285,89348,765737,791Nov 28 07:29 PM
Michels Douglas APresident & CEONov 23Sale9.0230,893278,711731,898Nov 28 07:29 PM
KUNA MARK LSVP & ControllerNov 23Sale9.027,13164,32272,965Nov 25 05:55 PM
JERRETT JACK ESVP & General CounselNov 23Sale9.0024,000216,00048,105Nov 25 05:53 PM
KUNA MARK LSVP & ControllerNov 22Option Exercise5.1915,00077,85087,965Nov 25 05:55 PM
KUNA MARK LSVP & ControllerNov 22Sale8.8815,000133,24580,096Nov 25 05:55 PM
Michels Douglas APresident & CEOSep 26Sale8.2225,000205,525756,898Sep 28 05:40 PM
Patrick Charles WDirectorAug 31Sale8.5817,483150,00414,905Aug 31 05:24 PM
JERRETT JACK ESVP & General CounselAug 30Option Exercise4.7936,415174,529116,791Aug 31 05:26 PM
JERRETT JACK ESVP & General CounselAug 30Sale8.5268,686585,42248,105Aug 31 05:26 PM
Patrick Charles WDirectorAug 29Sale8.942,25020,11574,959Aug 31 05:24 PM
Patrick Charles WDirectorAug 05Sale7.246,57547,60377,209Aug 31 05:24 PM